Levi & Korsinsky, LLP announces the filing of a class action lawsuit in the USDC for the Southern District of New York on behalf of shareholders of Rockwell Medical, Inc. (NASDAW: RMTI) (“Rockwell Medical” or “the Company”) who purchased shares between September 9, 2015 and February 29, 2016.
The complaint alleges that the Company failed to disclose that: (1) Rockwell’s main product offering for Triferic has not yet been approved by the FDA; and (2) Rockwell is seeking to obtain transitional add-on payment reimbursement for Triferic with the Centers for Medicare & Medicaid Services instead of bundled reimbursement.
If you suffered a loss in Rockwell you have until May 3, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
To receive more information, please fill out the form.